Home / Pharmaceuticals / Angioedema Treatment Market By Treatments (Antihistamines, Cortecosteroids, Autoimmune Drugs, Antifibrinolytic Agents, Blood Protein Controllers), By Pipeline (Phase I, Phase II, Phase III) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Angioedema Treatment Market By Treatments (Antihistamines, Cortecosteroids, Autoimmune Drugs, Antifibrinolytic Agents, Blood Protein Controllers), By Pipeline (Phase I, Phase II, Phase III) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: Jul 2016 | Report Code: 58017-07-16

Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan.  Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.

The treatments studies for analyzing the overall angioedema treatment market are Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Market size and forecast for each of these segments for the period 2014-2022 are provided in this study along with respective CAGRs for the forecast period 2016-2022. This report also highlights information about major clinical trial candidates under scrutiny for angioedema treatment. These candidates are categorized corresponding to their trial phase, namely phase I, phase II and phase III.

Geographically, the global angioedema treatment market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Middle East and Africa
  • Latin America

Market size and forecast for these regional and country level markets are presented in this study for the period 2014-2022. Market growth rates for the forecast period 2016-2022 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global angioedema treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global angioedema treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in angioedema treatment market.

Angioedema Treatment Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global Angioedema Treatment Market Portaiture
2.2 Global Angioedema Treatment Market, by Treatment, 2015 (USD Mn)
2.3 Angioedema Treatment Market Share, by Geography, 2015 (Value %)

Chapter 3 Angioedema Treatment : Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.2 Rising Geriatric Population
3.3.1.3 Government Initiative
3.3.2 Challenges
3.3.2.1 Slow Responding Commercialization Of New & Effective Therapies
3.3.3 Opportunities
3.3.3.1 Technological Advancements
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis By Key Players, 2015 (Value %)

Chapter 4 Global Angioedema Treatment Market, by Treatments
4.1 Preface
4.2 Antihistamines
4.1 Cortecosteroids
4.2 Autoimmune Drugs
4.1 Antifibrinolytic Agents
4.2 Blood Protein Controllers

Chapter 5 Global Angioedema Treatment Market, By Pipeline Treatment Analysis
4.3 Overview
4.3 Phase I
4.3 Phase II
4.3 Phase III

Chapter 6 Global Angioedema Treatment Market, By Geography
6.1 Overview
6.2 North America
4.2.1. U.S.
4.2.2. Canada
6.3 Europe
4.2.1. U.K.
4.2.2. Germany
4.2.3. Rest of Europe
6.4 Asia Pacific
4.2.1. Japan
4.2.2. China
4.2.3. Rest of Asia Pacific
6.4 Latin America
6.5 Middle East and Africa

Chapter 7 Company Profiles
7.1 AstraZeneca plc
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Portfolio
7.1.4 News Coverage
7.2 F. Hoffmann-La Roche AG
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Portfolio
7.2.4 News Coverage
7.3 Valeant Pharmaceuticals International.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Portfolio
7.3.4 News Coverage
7.4 Merck & Co.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Portfolio
7.4.4 News Coverage
7.5 Dyax Corp
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Portfolio
7.5.4 News Coverage
7.6 CSL Behring
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product portfolio
7.6.4 News Coverage
7.7 Pharming Group
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Portfolio
7.7.4 News Coverage
7.8 ViroPharma
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Portfolio
7.8.4 News Coverage
7.9 Other Notable Players

List of Figures

FIG. 1 Global Angioedema Treatment Market, by Treatment, 2015 (USD Mn)
FIG. 2 Global Angioedema Treatment Market Share, by Geography, 2015 (Value %)
FIG. 3 Attractive Investment Proposition, Global Angioedema Treatment Market, 2015
FIG. 4 Market Share Analysis By Key Players, 2015 (Value %)
FIG. 5 Global Antihistamines Market Revenue, 2013 – 2022 (USD Mn)
FIG. 6 Global Cortecosteroid Market Revenue, 2013 – 2022 (USD Mn)
FIG. 7 Global Autoimmune Drugs Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Antifibrinolytic Agents Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Blood Protein Controllers Market Revenue, 2013 – 2022 (USD Mn)

List of Tables

TABLE 1 Global Angioedema Treatment Revenue, by Treatment Type, 2013 – 2022 (USD Mn)
TABLE 2 Global Angioedema Treatment Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 3 Angioedema Pipeline Analysis (Phase I)
TABLE 4 Angioedema Pipeline Analysis (Phase II)
TABLE 5 Angioedema Pipeline Analysis (Phase III)
TABLE 6 North America Angioedema Treatment Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Europe Angioedema Treatment Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Asia - Pacific Angioedema Treatment Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 8 Latin America Angioedema Treatment Market Revenue, by Regions, 2013 – 2022 (USD Mn)

Based on the type of treatment the global angioedema treatment market is segmented as follows:

  • Antihistamines
  • Corticosteroid
  • Autoimmune Drugs
  • Antifibrinolytic Agents
  • Blood Protein Controllers

Angioedema, also known as angioneurotic edema, is the rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa and submucosal tissues. Angioedema is one of the common condition caused due to allergies and show sudden swelling under the skin surface. Angioedema can be caused due allergy of food, medication, environmental factors, genetic reasons and common allergens. There are four common forms of angioedema such as allergic angioedema, idiopathic angioedema, drug-induced angioedema and hereditary angioedema. The treatments for angioedema include normal physical examination, and proper drugs for the prevention for the attacks in the patients. The drugs treatments include Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Antihistamines and Corticosteroids accounted for approximately 45% - 50% of the total market share because these are the first line therapies preferred by the medical practitioners and majorly used as supportive therapies and most accessible source of treatment across the globe.

Angioedema Treatment Market

For the purpose of this study, the global angioedema treatment market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Angioedema Treatment Market

The geographical segmentation of the global market for angioedema treatment market comprises North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. In base year 2015, North America accounted for the largest market in the agioedema treatment market due to rising number of angioedema patients in U.S. along with the rising awareness among the patients are the key factors contributing towards the growth of angioedma treatment market in this region. An 20% of the population are affected angioedema in North America. Contemporary medical management of angioedema is divided between treatment of acute attacks and short- and long-term prophylaxis to reduce both the frequency and severity of subsequent flare-ups. Worldwide, the incidence of angioedema is approximately 1 in 30,000 to 50,000 persons. Europe held the second largest market in the angioedema treatment market. The high prevalence rate of angioedema in Europe is the driving factor for the growth of the market. Moreover, the rising government initiative to increase awareness regarding angioedema would further grow the market in Europe. Asia Pacific is expected to be the fastest growing market in the global angioedema market due to rising prevalence rate in the countries like Japan, China and others. Moreover, the growing research and development in the drug discovery of  angioedema would further drive the market during the forecast period.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients